Abstract
G-protein coupled receptors (GPCRs) are the largest single family of signaling molecules in mammals and represent approximately 2-3% of all genes in the human genome. Estimates of the total number of GPCR genes in the human genome range from about 750 to 1000. GPCRs mediate signaling by a wide variety of ligands including amino acids, ions, biogenic amines, peptides, glycoproteins, light, pheromones, and odorants. There are presently only a handful of GPCRs whose structures have been elucidated. Of these, the mGluR1 subtype of metabotropic glutamate receptor (mGluR) and rhodopsin are the most widely used in modeling GPCRs. In the case of mGluR1, the three-dimensional structure of the extracellular ligand binding domain of the molecule has been solved, while the crystallographic data for rhodopsin encompasses the whole protein in the ground state with bound 11-cis-retinal. In this review, we discuss the use of homology modeling to investigate the structures and functions of GPCRs. We illustrate the use of homology modeling with a particular emphasis on ligand and drug binding sites in the Family C subfamily of GPCRs.
Keywords: Homology modeling, ligand-receptor interaction, ligand docking, mGluR, Family C GPCRs, cysteine-rich domain, allosteric modulato
Current Computer-Aided Drug Design
Title: An Introduction to Molecular Modeling of G-Protein Coupled Receptors
Volume: 2 Issue: 3
Author(s): Minghua Wang, Lakshmi P. Kotra and David R. Hampson
Affiliation:
Keywords: Homology modeling, ligand-receptor interaction, ligand docking, mGluR, Family C GPCRs, cysteine-rich domain, allosteric modulato
Abstract: G-protein coupled receptors (GPCRs) are the largest single family of signaling molecules in mammals and represent approximately 2-3% of all genes in the human genome. Estimates of the total number of GPCR genes in the human genome range from about 750 to 1000. GPCRs mediate signaling by a wide variety of ligands including amino acids, ions, biogenic amines, peptides, glycoproteins, light, pheromones, and odorants. There are presently only a handful of GPCRs whose structures have been elucidated. Of these, the mGluR1 subtype of metabotropic glutamate receptor (mGluR) and rhodopsin are the most widely used in modeling GPCRs. In the case of mGluR1, the three-dimensional structure of the extracellular ligand binding domain of the molecule has been solved, while the crystallographic data for rhodopsin encompasses the whole protein in the ground state with bound 11-cis-retinal. In this review, we discuss the use of homology modeling to investigate the structures and functions of GPCRs. We illustrate the use of homology modeling with a particular emphasis on ligand and drug binding sites in the Family C subfamily of GPCRs.
Export Options
About this article
Cite this article as:
Wang Minghua, Kotra P. Lakshmi and Hampson R. David, An Introduction to Molecular Modeling of G-Protein Coupled Receptors, Current Computer-Aided Drug Design 2006; 2 (3) . https://dx.doi.org/10.2174/157340906778226409
DOI https://dx.doi.org/10.2174/157340906778226409 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Focus on Microfluidics and Nanotechnology Approaches for the Ultra Sensitive Detection of MicroRNA
MicroRNA Malononitrile as a Key Reagent in Multicomponent Reactions for the Synthesis of Pharmaceutically Important Pyridines
Current Organic Chemistry Systematic Comparison of the Performance of Different 2D and 3D Ligand-Based Virtual Screening Methodologies to Discover Anticonvulsant Drugs
Combinatorial Chemistry & High Throughput Screening Subtype-Selective Noncompetitive Modulators of Metabotropic Glutamate Receptor Subtype 1 (mGluR1)
Current Topics in Medicinal Chemistry Pharmacological Interference With Protein-protein Interactions of Akinase Anchoring Proteins as a Strategy for the Treatment of Disease
Current Drug Targets A Comprehensive Review on Preclinical Evidence-based Neuroprotective Potential of <i>Bacopa monnieri</i> against Parkinson's Disease
Current Drug Targets Expression and Function of Cytochrome P450 in Brain Drug Metabolism
Current Drug Metabolism Role of Nitric Oxide and Calpain Activation in Neuronal Death and Survival
Current Drug Targets - CNS & Neurological Disorders Nano-Neurotherapeutics (NNTs): An Emergent and Multifaceted Tool for CNS Disorders
Current Drug Metabolism Structure-Activity Studies on Alpha-Conotoxins
Current Pharmaceutical Design Heterotrimeric G Proteins Control Diverse Pathways of Transmembrane Signaling, a Base for Drug Discovery
Mini-Reviews in Medicinal Chemistry Allosteric Targeting of Aurora A Kinase Using Small Molecules: A Step Forward Towards Next Generation Medicines?
Current Medicinal Chemistry Pharmacological Properties and Therapeutic Potential of Naringenin: A Citrus Flavonoid of Pharmaceutical Promise
Current Pharmaceutical Design Scorpion Extracts Inhibit Tumor Growth in Esophageal Cancer and Lung Adenocarcinoma
Current Signal Transduction Therapy Extraction, GC-MS Evaluation and Anti-epileptic Potential of Seeds Ethanolic Extract of Putranjiva roxburghii Wall
Central Nervous System Agents in Medicinal Chemistry Approaches for the Development of Drugs for Treatment of Obesity and Metabolic Syndrome
Current Pharmaceutical Design Recent Advances in the Medicinal Chemistry of Sodium Channel Blockers and their Therapeutic Potential
Current Topics in Medicinal Chemistry mTOR: A Novel Therapeutic Target for Diseases of Multiple Systems
Current Drug Targets Aquaporins and Glia
Current Neuropharmacology Intracerebrally Applied Botulinum Neurotoxin in Experimental Neuroscience
Current Pharmaceutical Biotechnology